Impact of different definitions of airflow limitation on the prevalence of chronic obstructive pulmonary disease in the general population

Respiration

Volumn 80, Issue 4, 2010, Pages 292-300

  Gläser, Sven ^a   Schäper, Christoph ^a   Obst, Anne ^a   Ittermann, Till ^a   Völzke, Henry ^a   Felix, Stephan B ^a   Vogelmeier, Claus ^b   Dörr, Marcus ^a   Ewert, Ralf ^a   Koch, Beate ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Airflow limitation; Chronic obstructive pulmonary disease; Prevalence of pulmonary diseases; Smoking

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PLETHYSMOGRAPHY, WHOLE BODY; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS;

EID: 77957007207     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000282171     Document Type: Article

References (39)

1. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E: International variation in the prevalence of COPD (the BOLD study): a population-based prevalence study. Lancet 2007; 370: 741-750.
2. Lin HH, Murray M, Cohen T, Colijn C, Ezzati M: Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in china: a time-based, multiple risk factor, modelling study. Lancet 2008; 372: 1473-1483.
3. Pellegrino R, Brusasco V, Viegi G, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, Macintyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J: Definition of COPD: based on evidence or opinion? Eur Respir J 2008; 31: 681-682.
4. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/ WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
5. Global Initiative for Obstructive Lung Disease: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease-Update 2008. http://www.goldcopd.com/.
6. Mannino DM, Ford ES, Redd SC: Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. J Intern Med 2003; 254: 540-547.
7. Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-187.
8. Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, Jensen RL, Falaschetti E, Schouten JP, Hankinson JL, Stocks J, Quanjer PH: Using the lower limit of normal for the FEV 1 /FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-1051.
9. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O: Risk of over-diagnosis of COPD in asymptomatic elderly neversmokers. Eur Respir J 2002; 20: 1117-1122.
10. Hansen JE, Sun XG, Wasserman K: Spirometric criteria for airway obstruction: use percentage of FEV 1 /FVC ratio below the fifth percentile, not ! 70%. Chest 2007; 131: 349-355.
11. Brutsche MH, Downs SH, Schindler C, Gerbase MW, Schwartz J, Frey M, Russi EW, Ackermann-Liebrich U, Leuenberger P, SAPALDIA Team: Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA cohort study. Thorax 2006; 61: 671-677.
12. de Marco R, Accordini S, Cerveri I, Corsico A, Sunyer J, Neukirch F, Kunzli N, Leynaert B, Janson C, Gislason T, Vermeire P, Svanes C, Anto JM, Burney P: An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages. Thorax 2004; 59: 120-125.
13. Tashkin DP, Celli B, Decramer M, Liu D, Burkhart D, Cassino C, Kesten S: Bronchodilator responsiveness in patients with COPD. Eur Respir J 2008; 31: 742-750.
14. Soriano JB, Mannino DM: Reversing concepts on COPD irreversibility. Eur Respir J 2008; 31: 695-696.
15. John U, Greiner B, Hensel E, Ludemann J, Piek M, Sauer S, Adam C, Born G, Alte D, Greiser E, Haertel U, Hense HW, Haerting J, Willich S, Kessler C: Study of health in Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed 2001; 46: 186-194.
16. Koch B, Schaper C, Ittermann T, Spielhagen T, Dorr M, Volzke H, Opitz CF, Ewert R, Glaser S: Reference values for cardiopulmonary exercise testing in healthy volunteers: the SHIP study. Eur Respir J 2009; 33: 389-397.
17. WHO: ATC Index with DDDS. Guidelines for ATC Classification and DDD assignment. Oslo, WHO Collaborating Centre for Drug Statistics Methodology, 2008.
18. Standardization of spirometry-1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136: 1285-1298.
19. Standardization of spirometry-1987 update. Official statement of American Thoracic Society. Respir Care 1987; 32: 1039-1060.
20. Nelson SB, Gardner RM, Crapo RO, Jensen RL: Performance evaluation of contemporary spirometers. Chest 1990; 97: 288-297.
21. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 16(suppl):5-40.
22. Measuring Obesity-Classification and Description of Anthropometric Data. Report on a WHO Consultation of the Epidemiology of Obesity. Warsaw, World Health Organization, 1987.
23. Koenker R: Quantile Regression. Econometric Society Monographs. New York, Cambridge University Press, 2005.
24. Miller MR, Pincock AC: Predicted values: how should we use them? Thorax 1988; 43: 265-267.
25. Dixon WJ, Massey FJ Jr: Introduction to Statistical Analysis, ed 3. New York, McGraw-Hill, 1969, pp 461-463.
26. Bridevaux PO, Gerbase MW, Probst-Hensch NM, Schindler C, Gaspoz JM, Rochat T: Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 2008; 63: 768-774.
27. Kuster SP, Kuster D, Schindler C, Rochat MK, Braun J, Held L, Brandli O: Reference equations for lung function screening of healthy never-smoking adults aged 18-80 years. Eur Respir J 2008; 31: 860-868.
28. Schirnhofer L, Lamprecht B, Vollmer WM, Allison MJ, Studnicka M, Jensen RL, Buist AS: COPD prevalence in Salzburg, Austria: results from the burden of obstructive lung disease (BOLD) study. Chest 2007; 131: 29-36.
29. Geldmacher H, Biller H, Herbst A, Urbanski K, Allison M, Buist AS, Hohlfeld JM, Welte T: The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study (in German). Dtsch Med Wochenschr 2008; 133: 2609-2614.
30. Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, Menezes AM, Crapo RO, Jensen RL, Burney PG: The burden of obstructive lung disease initiative (BOLD): rationale and design. COPD 2005; 2: 277-283.
31. Volzke H, Neuhauser H, Moebus S, Baumert J, Berger K, Stang A, Ellert U, Werner A, Doring A: Urban-rural disparities in smoking behaviour in Germany. BMC Public Health 2006; 6: 146.
32. Nizankowska-Mogilnicka E, Mejza F, Buist AS, Vollmer WM, Skucha W, Harat R, Pajak A, Gasowski J, Frey J, Nastalek P, Twardowska M, Janicka J, Szczeklik A: Prevalence of COPD and tobacco smoking in Malopolska region-results from the BOLD study in Poland. Pol Arch Med Wewn 2007; 117: 402-410.
33. McCurdy SA, Sunyer J, Zock JP, Anto JM, Kogevinas M: Smoking and occupation from the European Community Respiratory Health Survey. Occup Environ Med 2003; 60: 643-648.
34. Volzke H, Neuhauser H, Moebus S, Baumert J, Berger K, Stang A, Ellert U, Werner A, Ding A: Rauchen: Regionale Unterschiede in Deutschland. Dtsch Arztebl 2006; 103: 2784-2790.
35. Yin P, Jiang CQ, Cheng KK, Lam TH, Lam KH, Miller MR, Zhang WS, Thomas GN, Adab P: Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet 2007; 370: 751-757.
36. Johannessen A, Omenaas ER, Bakke PS, Gulsvik A: Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005; 60: 842-847.
37. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J: Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
38. Johannessen A, Lehmann S, Omenaas ER, Eide GE, Bakke PS, Gulsvik A: Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 2006; 173: 1316-1325.
39. Carre PC, Roche N, Neukirch F, Radeau T, Perez T, Terrioux P, Ostinelli J, Pouchain D, Huchon G: The effect of an information leaflet upon knowledge and awareness of COPD in potential sufferers. A randomized controlled study. Respiration 2008; 76: 53-60.